What are the sensitivity and specificity of rapid antigen detection tests for group A streptococcal pharyngitis in children and adolescents (ages 3–21 years), and should a negative rapid test be followed by a reflex throat culture?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sensitivity and Specificity of Rapid Antigen Detection Tests for Group A Streptococcal Pharyngitis in Children and Adolescents

RADTs for group A streptococcal pharyngitis in children and adolescents (ages 3–21 years) demonstrate a sensitivity of 80–90% and specificity ≥95%, and a negative RADT must be followed by a reflex throat culture in this age group because the test misses 10–20% of true infections. 1, 2

Test Performance Characteristics

  • The specificity of RADTs is ≥95%, making false-positive results rare (≤5%), which means therapeutic decisions can be made with confidence based on a positive test result without requiring confirmatory culture. 1, 3

  • The sensitivity of RADTs ranges from 80–90% when compared with blood agar plate culture, the gold standard for diagnosis. 1, 2, 4

  • This 10–20% false-negative rate is clinically significant because studies demonstrate that a large proportion of patients with false-negative RADT results are truly infected with group A β-hemolytic streptococci and are not merely asymptomatic carriers. 1

  • The Khan et al. (2021) study of 202 pediatric emergency department patients found RADT sensitivity of 79% and specificity of 90%, with no significant differences between 3–10 year olds and 11–21 year olds, confirming that test performance is consistent across pediatric age groups. 5

  • The Cohen et al. (2016) systematic review and meta-analysis of 98 studies (101,121 participants) found summary sensitivity of 85.6% and specificity of 95.4%, providing high-quality evidence that in a population with 30% GAS prevalence, RADT alone would miss 14% of true positive cases. 4

Age-Specific Testing Algorithms

Children and Adolescents (Ages 3–21 Years)

  • Perform a RADT first; a positive result (specificity ≥95%) obviates the need for a backup throat culture and allows immediate initiation of antibiotic therapy. 1, 2

  • If the RADT is negative, obtain a mandatory backup throat culture because RADT sensitivity is only 80–90%, missing 10–20% of true infections in this age group. 1, 2

  • This two-step testing approach is required in pediatric patients because of the higher prevalence of GAS pharyngitis (20–30% in ages 5–15 years) and the meaningful risk of acute rheumatic fever and long-term cardiac sequelae. 1, 2

  • Treatment can be initiated within 9 days of symptom onset and still effectively prevent acute rheumatic fever, so waiting for culture results (24–48 hours) does not compromise prevention of complications. 1, 2

Adults (Not Applicable to This Question)

  • In adults, a negative RADT alone is sufficient to rule out GAS without a backup culture, given the low prevalence (5–10%) and extremely low risk of acute rheumatic fever. 1, 2

Clinical Rationale for Reflex Culture

  • The primary justification for treating confirmed GAS pharyngitis is prevention of acute rheumatic fever, which remains a risk in the pediatric population, particularly ages 5–15 years. 1, 2

  • In a population with 30% GAS prevalence, RADT alone would miss approximately 43 cases per 1000 children tested (based on 85.6% sensitivity), making reflex culture essential to identify these missed infections. 4

  • The 10-day antibiotic course required to prevent acute rheumatic fever can be initiated after culture confirmation without compromising efficacy, as treatment within 9 days of symptom onset is protective. 1, 2

Newer Testing Technologies

  • Newer nucleic acid amplification tests (NAATs) demonstrate higher sensitivity than traditional RADTs but face limitations including cost, complexity, and concerns about detecting asymptomatic carriers rather than true infections. 2

  • An immunofluorescence-based RADT showed improved sensitivity of 84.9% compared to 75.3% for standard immunochromatographic tests in a 2018 study, though this still falls short of the sensitivity needed to eliminate reflex culture in children. 6

  • Loop-mediated isothermal amplification (LAMP) assays have shown sensitivity approaching culture (detecting 70/71 GAS-positive samples versus 55/71 for culture alone), but these are not yet widely adopted in clinical practice. 7

Common Pitfalls to Avoid

  • Do not rely on a negative RADT alone in children and adolescents; the 10–20% false-negative rate is unacceptable given the risk of acute rheumatic fever in this population. 1, 2

  • Do not order confirmatory cultures for positive RADT results; the ≥95% specificity makes this unnecessary and wasteful. 1, 3

  • Prior antibiotic use can cause false-negative RADT results by reducing bacterial load below the detection threshold, compounding the inherent sensitivity limitations and making reflex culture even more critical. 8

  • Ensure proper swabbing technique by sampling both tonsils (or tonsillar fossae) and the posterior pharyngeal wall, as technique significantly impacts test yield. 2, 8

  • Do not assume patients with false-negative RADTs are merely carriers; studies demonstrate that most are truly infected and require treatment. 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.